Psychiatrists often describe electroconvulsive therapy (ECT) as “safe and effective”.
Three recent reports show a different side to ECT.
An inquest in May and June 2026 heard that a 69-year-old woman collapsed during her third ECT treatment in December 2022 and died of a heart attack the following day. She had been sectioned and admitted to Heathfield Ward at the Eastbourne District General Hospital after having difficulty eating and drinking and three suicide attempts. One of the findings of the jury was: “The consultant psychiatrist and anaesthetist did not have satisfactory medical information for Neeshat prior to the ECT treatment on 13.12.22, and so postponement was not considered in light of this.” Assistant coroner for East Sussex, Rachel Redman, made a prevention of future deaths report. This report did not mention ECT; it concerned the need for “provision of appropriately qualified dieticians who can meet the nutritional needs of inpatients undergoing psychiatric care”.
In July 2026 researchers in Japan published an article in Epilepsia (Masahiro Hata et al. Cumulative electroconvulsive therapy sessions and focal epilepsy: A nationwide cohort study in Japan, Epilepsia, July 2026, online ahead of print) in which they described how they had looked at a cohort of 3,733 ECT patients to see how many received a diagnosis of focal epilepsy during or after ECT. The mean age of the patients was 57 and two-thirds were women. Ninety-six (2.6%) developed focal epilepsy, with an association between the number of ECT treatments and the likelihood of developing focal epilepsy. The authors concluded: “Although this study cannot determine whether ECT causes epilepsy, our findings suggest that careful neurological monitoring may be considered during extended treatment.” Another article by three of the same authors, using the same cohort of ECT patients, revealed that patients receiving large amounts of ECT were more likely to be women. Of patients receiving more than 100 treatments, 77% were women. (M Hata, Y Miyazaki, S Takahashi. Patients Receiving 100 or More Electroconvulsive Therapy Treatments in a Nationwide Cohort, Acta Psychiatrica Scandinavica, 26 August 2026.)
In France, a team of two anaesthetists and three psychiatrists from Nantes University published an article in L’Encéphale (Camille Rouvière et al. A naturalistic study on anaesthesia awareness during electroconvulsive therapy, L’Encéphale, 2026, 52 (4), pp.400 – 405). They found that there were six instances of anaesthetic awareness with recall in four patients from 364 patients treated with ECT at Nantes University Hospital Centre from 2020 to 2024. Two patients discontinued treatment. The authors write:
“AAWR during ECT represents a major clinical and ethical concern, as it can lead to psychological trauma, loss of trust in medical care, and subsequent refusal of ECT or other procedures requiring anaesthesia, thereby compromising the management of severe psychiatric disorders. More broadly, PTSD induced by AAWR can cause excessive fear and refusal of any subsequent anaesthesia procedures, whether for ECT or other treatments (e.g., surgery, preventive procedures such as colonoscopies), which has a major impact on patients’ health.”